OCULAR THERAPEUTIX, INC Current Liabilities
OCULAR THERAPEUTIX, INC (OCUL) had Current Liabilities of $49.17 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-03
- 2026-06-30: Liabilities, Current $49.17M.
- 2026-03-31: Liabilities, Current $47.68M.
- 2025-12-31: Liabilities, Current $50.81M.
- 2025-09-30: Liabilities, Current $49.29M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $49.17M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $47.68M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $50.81M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $49.29M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $42.93M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $37.93M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $41.35M 10-K · filed 2026-02-05 |
| 2024-09-30 | $36.36M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $29.97M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $24.30M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $34.90M 10-K · filed 2025-03-03 |
| 2023-09-30 | $35.07M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $32.36M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $29.71M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $31.39M 10-K · filed 2024-03-11 |
| 2022-09-30 | $29.27M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $26.11M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $23.96M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $26.34M 10-K · filed 2023-03-06 |
| 2021-09-30 | $25.16M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $21.55M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $27.44M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $26.66M 10-K · filed 2022-02-28 |
| 2020-09-30 | $22.91M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $13.80M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $11.11M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $12.03M 10-K · filed 2021-03-11 |
| 2019-09-30 | $11.01M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $10.13M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $8.61M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $9.16M 10-K · filed 2020-03-12 |
| 2018-09-30 | $13.41M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $11.90M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $13.15M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $13.43M 10-K · filed 2019-03-07 |
| 2017-09-30 | $10.95M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $13.13M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $8.66M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $8.30M 10-K · filed 2018-03-08 |
| 2016-09-30 | $8.24M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $6.42M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $6.00M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $5.38M 10-K · filed 2017-03-10 |
| 2015-09-30 | $11.18M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $9.59M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $7.23M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $5.87M 10-K · filed 2016-03-10 |
| 2014-09-30 | $3.38M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $4.49M 10-Q · filed 2014-08-29 |
| 2013-12-31 | $3.34M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |